Epicrispr Biotechnologies vs MediWound
Epicrispr Biotechnologies vs MediWound, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and MediWound on 47/100.
Where each one leads
Epicrispr Biotechnologies
- our overall score: 62/100 against 47/100
- funding raised: $90.0M against $25.0M
MediWound
- agent readiness: 45/100 against 39/100
- headcount: 105 against 51
At a glance
| Measure | Epicrispr Biotechnologies | MediWound |
|---|---|---|
| What it is | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). | Global leader in enzymatic therapeutics for non-surgical tissue repair, replacing existing standards of care. |
| Category | Biotechnology, Therapeutics, Rare Diseases, Epigenetics | Healthcare, MedTech, HealthTech, Biotechnology |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2020 | 2000 |
| Headquarters | South San Francisco, United States | Yavne, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Epicrispr Biotechnologies | MediWound |
|---|---|---|
| Employees | 51 | 105 |
| Total funding | $90.0M | $25.0M |
| Latest round | Series C | Post-IPO |
| LinkedIn followers | 7,025 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epicrispr Biotechnologies | MediWound |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 47/100 |
| Traction | 57/100 | 59/100 |
| Team | 40/100 | Not published |
| Search visibility | 20/100 | 4/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (45/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 42/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epicrispr Biotechnologies | MediWound |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Jquery |
| Analytics | Google Analytics 4 | Not detected |
Epicrispr Biotechnologies vs MediWound: common questions
Which is better, Epicrispr Biotechnologies or MediWound?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 47/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Epicrispr Biotechnologies and MediWound compare on the numbers?
Epicrispr Biotechnologies leads on our overall score (62/100 against 47/100), funding raised ($90.0M against $25.0M). MediWound leads on agent readiness (45/100 against 39/100), headcount (105 against 51).
Read the full Epicrispr Biotechnologies review and pricing or the MediWound review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.